An investigation on behalf of investors in Asterias Biotherapeutics Inc (NYSEMKT:AST) shares over potential wrongdoing at Asterias Biotherapeutics Inc was announced and NYSEMKT:AST stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 06/14/2016 -- An investigation was announced on behalf of current long-term investors in shares of Asterias Biotherapeutics Inc (NYSEMKT:AST) over potential breaches of fiduciary duties by certain directors at Asterias Biotherapeutics.
Investors who purchased shares of Asterias Biotherapeutics Inc (NYSEMKT:AST) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Asterias Biotherapeutics directors breached their fiduciary duties.
Asterias Biotherapeutics Inc reported that its annual Total Revenue rose from $1.22 million in 2014 to $3.58 million in 2015 and that its Net Loss increased from $10.10 million in 2014 to$15.00 million in 2015.
Shares of Asterias Biotherapeutics Inc (NYSEMKT:AST) declined from $14.77 per share in April 2015 to as low as $2.60 per share in January 2016.
On June 10, 2016, NYSEMKT:AST shares closed at $3.00 per share.
Those who purchased shares of Asterias Biotherapeutics Inc have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com